Pioneering breakthroughs in antibiotic discovery to improve lives worldwide
Pioneering breakthroughs in antibiotic discovery to improve lives worldwide
At Donum Therapeutics, our antibacterial discovery approach has been based on identifying bacteria that produce antibiotics that already act systemically in an animal, which implies a biosynthetic imperative to endow their metabolites with drug-like properties.
With decades of combined experience in antimicrobial resistance mechanisms, antibiotic drug discovery and development, medicinal chemistry and corporate development, our team has the expertise and knowledge to develop products that are effective, safe, and sustainable.
We are committed to innovation, developing new technologies to combat antimicrobial resistance through discovery of new antibacterial drug classes and solutions that address the world's most pressing challenges pandemic antibiotic resistance.
Our pipeline presently consists of a series of natural variants of darobactin and dynobactin, both of which target BamA, at the Lead Optimization stage of development
Copyright © 2024 Donum Therapeutics - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.